ALLY Energy's sixth annual GRIT Awards, which will honor leaders in the energy industry, will take place on October 26. Photo via ALLY Energy

Houston Mayor Sylvester Turner and three energy executives have been named first-time winners of lifetime achievement awards as part of ALLY Energy’s sixth annual GRIT Awards and Best Energy Workplaces program.

ALLY Energy says the honorees have demonstrated “a distinguished career championing change in energy and climate in the private or public sector in the areas of technology, policy, and workforce.”

As mayor of Houston, Turner has led efforts to use renewable energy throughout the city.

The other winners of lifetime achievement awards are:

  • Elizabeth Gerbel, founder and CEO of Houston-based EAG Services and EAG 1Source, which provide consulting services for the energy industry.
  • Lorenzo Simonelli, CEO of Houston-based oilfield services company Baker Hughes.
  • Kevin Sagara, executive vice president and group president of San Diego-based utility company Sempra. He is chairman of Sempra-owned San Diego Gas & Electric Co. and Southern California Gas Co.

The lifetime achievement honorees will be recognized October 26 during an event at The Bell Tower in Houston. So will the winners in the GRIT Awards and Best Energy Workplaces program. The keynote speaker will be U.S. Department of Energy official Shalanda Baker.

“This year’s GRIT Awards and Best Energy Workplaces finalists are a diverse cohort of game-changing entrepreneurs, gritty leaders, collaborative teams, and companies committed to combating climate change. The energy workforce is doing great things to transform our energy ecosystem, and we’re excited to spotlight exceptional talent and culture,” says Katie Mehnert, founder and CEO of Houston-based ALLY Energy, which provides a workforce development platform for the energy industry.

Among the dozens of award finalists are energy-related organizations or their representatives. These organizations include Baker Hughes, ExxonMobil, Halliburton, Marathon Oil, Rice University, Saudi Aramco, Shell, the University of Houston, Syzygy Plasmonics, and Wood Mackenzie.

A complete list of the finalists is available on the ALLY Energy website.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.